BPT Analytics Ltd launches ‘BPT20: Artificial Intelligence in Drug Discovery Productivity Index’
BPT20: AI in Drug Discovery Productivity Index
BPT20 Index includes the twenty drug design companies with some of the most advanced AI-platforms on the market
We have created the BPT20 AI Index as the industry’s point of reference to follow some of the most advanced AI in drug design companies worldwide. The Index will be updated once a year. Having reviewed more than 130 artificial intelligence (AI)-driven companies with a drug design focus out of more than 380 companies in our interactive report 'The Landscape of Artificial Intelligence (AI) In the Pharmaceutical R&D.' we have selected twenty leading companies to be included in this year’s BPT20 AI Index publication. While there are other top-notch AI companies in this industry, BPT20 is exclusively focused on companies with a focus on drug design and at least one clinical-stage asset in development.
You may also want to review the Roadmap of AI-developed Drug Candidates, a running list of the most advanced clinical stage molecules claimed to be developed using a big-data approach and AI tools.
Alongside with BPT20 AI Index, we have published a white paper, 'AI in Drug Discovery and Biotech: 2022 Recap and Key Trends', which summarizes the ongoing developments in this sector, revealing research and business trends. Some of the topics covered in the white paper include:
A role of deep learning, language models, and other AI-related technologies in pharma and biotech,
AI in drug discovery investment landscape, 2022
AI-enabled biology modeling and target discovery companies,
Cracking structural biology with AI
Developing small molecules using AI
AI meets DNA-encoded libraries
AI-driven drug design beyond small molecules
The first wave of AI-developed drug candidates goes clinical
AI and robotized labs of the future
Navigating clinical trial bottlenecks with AI
AI in the contract research industry
Technology giants expand into Life Sciences
The social media hashtag for the BPT20 AI index is #BPT20.
About BPT Analytics Ltd (BiopharmaTrend)
BPT Analytics (BiopharmaTrend) delivers science and business news, data, industry analytics reports, and interviews with KOLs, covering cutting-edge technologies, companies (startups), and trends in the pharmaceutical and biotech industries -- with a significant focus on artificial intelligence (AI), digital pharma, and new therapeutic modalities.
BiopharmaTrend is a creator of constantly updated interactive analytical reports available on a subscription basis.
On our website, we also maintain BPT Crunch -- an exclusive directory of innovative companies in the healthcare space -- specifically focused on early-stage players with breakthrough science and tech (from seed rounds to recent IPOs).
Follow us on Linkedin, and Twitter: @BiopharmaTrend
Andrii Buvailo
BPT Analytics Ltd
info@biopharmatrend.com
Visit us on social media:
Twitter
LinkedIn
Distribution channels: Healthcare & Pharmaceuticals Industry
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Submit your press release